FindTrial
Sign In

Effectiveness of cell-free and concentrated ascites reinfusion therapy in the treatment of gynecological malignant related ascites: A systematic review and meta-analysis

CART in gynecological malignancies - CART in gynecological malignancies

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000044822
Enrollment
200
Registered
2021-07-11
Start date
2021-07-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gynecological malignancies ascites

Interventions

None listed

Sponsors

Teikyo university hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) patients with gynecological malignant ascites, (2) data evaluating effectiveness of CART, and (3) detail information of procedure in CART was available.

Exclusion criteria

Exclusion criteria: (1) data of procedure only, (2) cirrhosis ascites only, and (3) no information identifying the efficieny of CART

Design outcomes

Primary

MeasureTime frame
Increased Albumin—

Countries

Japan

Contacts

Public ContactHao Chen

Teikyo university hospital Onclolgy

chinsmd@gmail.com03-3964-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026